Composition
- Active ingredients
- LANTHANUM CARBONATE EQ 250MG BASE
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- LANTHANUM CARBONATE EQ 1GM BASE · PowderNDA204734-002 · Prescription
- LANTHANUM CARBONATE EQ 750MG BASE · PowderNDA204734-001 · Prescription
- LANTHANUM CARBONATE EQ 500MG BASE · Tablet, chewableNDA021468-002 · Prescription
- LANTHANUM CARBONATE EQ 750MG BASE · Tablet, chewableNDA021468-003 · Prescription
- LANTHANUM CARBONATE EQ 250MG BASE · Tablet, chewableThis page
- LANTHANUM CARBONATE EQ 1GM BASE · Tablet, chewableNDA021468-004 · Prescription
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA021468.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Fosrenol
- Active substance
- lanthanum carbonate
- Route
- Oral
- Dosage form
- Tablet, chewable
- Applicant
- Takeda Pharms USA
- Status
- Discontinued
- FDA approval
- 26 Oct 2004
- Application
- NDA021468-001